CROI 2015 Program and Abstracts

Poster Listings

937 Sleep Disturbances in a Cohort of HIV-Infected Children and Adolescents on Antiretroviral Treatment: NeuroCoRISpeS Cristina García-Navarro 1 ; Santiago Jiménez de Ory 2 ; Maria Luisa Navarro Gomez 2 ; JoséTomás Ramos Amador 6 ; Maria Jose Mellado 3 ; Luis Prieto 5 ; Pablo Rojo Conejo 1 ; Esmeralda Nuñez 4 ; María Isabel González-Tomé 1 On behalf of the CoRISpeS‚ÄìMadrid Cohort 1 Hospital Universitario 12 de Octubre, Madrid, Spain; 2 Hospital Universitario Gregorio Marañón, Madrid, Spain; 3 Hospital Universitario La Paz, Madrid, Spain; 4 Hospital Regional Universitario Carlos Haya, Malaga, Spain; 5 Hospital Universitario de Getafe, Getafe, Spain; 6 Hospital Universitario Clinico San Carlos, Madrid, Spain; 7 Madrid, Madrid, Spain

943 Human Papillomavirus and Cervical Cytology in Perinatally Infected Asian Adolescents Annette H. Sohn 1 ; Stephen J. Kerr 2 ; Rawiwan Hansudewechakul 3 ;Wasana Prasitsuebsai 2 ; Kulkanya Chokephaibulkit 4 ;TruongV. Nguyen 5 ;Thoa P. Le 6 ;Thida Singtoroj 1 ; Nittaya Phanuphak 7 ; HPV in Adolescents Study 1 1 TREAT Asia/amfAR – The Foundation for AIDS Research, Bangkok, Thailand; 2 HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 3 Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; 4 Siriraj Hospital, Mahidol University, Bangkok, Thailand; 5 Hung Vuong Hospital, Ho Chi Minh City, Viet Nam; 6 Children’s Hospital 1, Ho Chi Minh City, Viet Nam; 7 SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand 944 Sexually Transmitted Infections in YouthWith Controlled and Uncontrolled HIV Andres F. Camacho-Gonzalez 1 ; Miriam C. Chernoff 2 ; Paige L.Williams 2 ; Ann Chahroudi 1 ; James M. Oleske 3 ; Rana Chakraborty 1 ; ShirleyTraite 2 ; Murli U. Purswani 4 ; Mark J. Abzug 5 On behalf of the IMPAACT P1074 StudyTeam 1 Emory University School of Medicine, Atlanta, GA, US; 2 Harvard School of Public Health, Center for Biostatistics in AIDS Research, Boston, MA, US; 3 Rutgers New Jersey Medical School, Newark, NJ, US; 4 Albert Einstein College of Medicine, Division of Pediatric Infectious Diseases, Bronx Lebanon Hospital Center, Bronx, NY, US; 5 University of Colorado School of Medicine, Division of Pediatric Infectious Diseases, Aurora, CO, US; 6 International Maternal Pediatric Adolescent AIDS Clinical Trials, Durham, NC, US 2:30 pm– 4:00 pm Responses to Vaccines in Children 945 Sustained Responses to Measles Revaccination in HIV-Infected Children on ART in Kenya Laura Newman 1 ; Anne Njoroge 1 ; Bhavna Chohan 1 ; Amalia Magaret 1 ; Jonathan Gorstein 1 ; Julie M. Overbaugh 2 ; DaltonWamalwa 3 ; Elizabeth M. Obimbo 3 ; RuthW. Nduati 3 ; Carey Farquhar 1 1 University of Washington, Seattle, WA, US; 2 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, US; 3 University of Nairobi, Nairobi, Kenya 946 T-Cell Anergy and Activation Are AssociatedWith Suboptimal Humoral Responses to Measles Revaccination in HIV-Infected Children on Antiretroviral Therapy in Nairobi, Kenya Matthew B. Buechler 1 ; Laura Newman 2 ; Bhavna Chohan 3 ; Anne Njorge 5 ; Dalton Wamalwa 6 ; Carey Farquhar 3 1 University of Washington, Seattle, WA, US; 2 University of Washington, Seattle, WA, US; 3 University of Washington, Seattle, WA, US; 4 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, US; 5 Kenyatta National Hospital, Nairobi, Kenya; 6 University of Nairobi, Nairobi, Kenya 947 Molecular Profiles of CXCR5+ CD4 Memory T Cells AssociatedWith Flu Vaccine Response Lesley R. de Armas 1 ; Nicola Cotugno 1 ; Suresh Pallikkuth 1 ; Alberto Cagigi 3 ; Paolo Palma 2 ; Paolo Rossi 2 ; Savita Pahwa 1 1 University of Miami Miller School of Medicine, Miami, FL, US; 2 Children’s Hospital Bambino Gesu, Rome, Italy; 3 Children Hospital Bambino Gesu, Rome, Italy 948 The Potential of BCG and HIV-TB Vaccines to Exacerbate HIV-1 Pathogenesis in Infants Kara Jensen 1 ; Koen K.Van Rompay 2 ;William R. Jacobs 3 ; Glenn Fennelly 3 ; Katie Mollan 1 ; Michael G. Hudgens 1 ; Mike Piatak 4 ; Michelle H. Larsen 3 ; Kristina De Paris 1 1 University of North Carolina, Chapel Hill, NC, US; 2 California National Primate Research Center, University of California, Davis, CA, US; 3 Albert Einstein College of Medicine, New York, NY, US; 4 Frederick National Laboratory, Frederick, MD, US TUESDAY, FEBRUARY 24, 2015 Session P-U9 Poster Session Poster Hall

WEDNESDAY, FEBRUARY 25, 2015 Session P-U8 Poster Session

Poster Hall

2:30 pm– 4:00 pm Tuberculosis and Other Coinfections in ChildrenWith HIV 938 Tuberculosis Among Children on Antiretroviral Therapy in Swaziland, 2004-2012 Melissa A. Briggs 1 ; Andrew Auld 1 ; Harrison Kamiru 2 ; Harriet Nuwagaba-Biribonwoha 2 ; Velephi Okello 3 ; George Bicego 1 ; Andrew L. Baughman 1 ; Simon Agolory 1 ;TeddV. Ellerbrock 1 ; Peter Ehrenkranz 4 1 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 2 Mailman School of Public Health, New York, NY, US; 3 Swaziland Ministry of Health, Mbabane, Swaziland; 4 US Centers for Disease Control and Prevention (CDC), Mbabane, Swaziland 939 Mycobacterium TB Disease in HIV-Infected Children Receiving LPV/r or NVP-Based ART Moherndran Archary 1 ; Linda Barlow-Mosha 2 ; AvyViolari 3 ; Jane Lindsey 4 ; Lynne Mofenson 4 ; Patrick Jean-Philipe 4 ; Bonnie Zimmer 4 ; Paul E Palumbo 5 1 University of KwaZulu-Natal, Durban, South Africa; 2 MUJHU Care Ltd/MUJHU Research Collaboration, Kampala, Uganda; 3 Perinatal HIV Research Unit, Johannesburg, South Africa; 4 Frontier Science, Amherst, NY, US; 5 Geisel School of Medicine at Dartmouth, Lebanon, NH, US 940 Safety of Rifabutin in HIV/TB-Coinfected Children on Protease Inhibitor- Based ART Holly E. Rawizza 1 ; Kristin M. Darin 2 ; Kimberly K. Scarsi 3 ; Biobele Brown 4 ; Regina Oladokun 4 ; Nkiru David 5 ; Sulaimon Akanmu 6 ; Oluremi Olaitan 7 ; Prosper Okonkwo 7 ; Phyllis Kanki 8 On behalf of the APIN PEPFARTeam 1 Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, US; 2 Northwestern University, Feinberg School of Medicine, Chicago, IL, US; 3 University of Nebraska Medical Center, Omaha, NE, US; 4 University College Hospital, Ibadan, Nigeria; 5 National Institute of Medical Research, Lagos, Nigeria; 6 Lagos University Teaching Hospital, Lagos, Nigeria; 7 AIDS Prevention Initiative in Nigeria, Abuja, Nigeria; 8 Harvard School of Public Health, Boston, MA, US 941 Skin Complaints in African Children Randomized to Stop or Continue Cotrimoxazole Andrew Prendergast 1 ; Mutsa F. Bwakura Dangarembizi 2 ; Peter Mugyenyi 3 ; Joseph Lutaakome 4 ; Adeodata Kekitiinwa 5 ; Diana M. Gibb 6 ; SarahWalker 6 On behalf of the ARROWTrialTeam 1 Queen Mary University of London, London, United Kingdom; 2 University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe; 3 JCRC, Kampala, Uganda; 4 MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda; 5 Baylor-Uganda, Kampala, Uganda; 6 MRC Clinical Trials Unit at University College London, London, United Kingdom 942 Disease Progression and Response to Treatment in Vertically HIV/HVC Co-infected Patients Talía Sainz 1 ; Carolina Fernández McPhee 2 ; Santiago Jimenez de Ory 1 ; Pablo Rojo 3 ; Maria del Carmen Otero 4 ; Milagros Garcia Lopez-Hortelano 5 ; Olaf Neth 7 ; Jose Beceiro 8 ; Maribel GonzálezTomé 3 ; María Luisa Navarro 6 On behalf of the Spanish Cohort of HIV-Infected Children and Adolescents (CoRISpe) 1 Hospital Universitario Gregorio Marañón, Madrid, Spain; 2 Hospital Ramón y Cajal, SEIM- Gesida, Madrid, Spain; 3 Hospital 12 de Octubre, Madrid, Spain; 4 Hospital La Fe, Valencia, Spain; 5 Hospital La Paz, Madrid, Spain; 6 Hospital Gregorio Marañón, Madrid, Spain; 7 Hospital Virgen del Rocio, Sevilla, Spain; 8 Hospital de Alcalá, Alcalá de Henares, Spain

Poster Listings

72

CROI 2015